Disease-specific overall survival in endometrioid ovarian
Descrição
Uterine Cancer (Endometrial Cancer): Symptoms & Treatment
Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemotherapy alone
Frontiers Systematic Lymph Node Dissection May Be Abolished in Patients With Apparent Early-Stage Low-Grade Mucinous and Endometrioid Epithelial Ovarian Cancer
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
Diagnostics, Free Full-Text
Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study, Journal of Ovarian Research
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study - The Lancet Oncology
Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial - The Lancet Oncology
CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma
Kaplan-Meier curves of disease-specific survival for high-grade serous
Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers, BMC Cancer
Treatment Patterns and Outcomes Among Patients With Advanced or Recurrent Endometrial Cancer Initiating First-Line Therapy in the United States
de
por adulto (o preço varia de acordo com o tamanho do grupo)
